[HTML][HTML] Staphylococcus aureus—A Known Opponent against Host Defense Mechanisms and Vaccine Development—Do We Still Have a Chance to Win?

U Wójcik-Bojek, B Różalska, B Sadowska - International journal of …, 2022 - mdpi.com
The main purpose of this review is to present justification for the urgent need to implement
specific prophylaxis of invasive Staphylococcus aureus infections. We emphasize the …

[HTML][HTML] Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies

J Clegg, E Soldaini, RM McLoughlin… - Frontiers in …, 2021 - frontiersin.org
Staphylococcus aureus is one of the most important human pathogens worldwide. Its high
antibiotic resistance profile reinforces the need for new interventions like vaccines in …

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

GH Dayan, N Mohamed, IL Scully, D Cooper… - Expert review of …, 2016 - Taylor & Francis
Staphylococcus aureus is both a commensal organism and also an important opportunistic
human pathogen, causing a variety of community and hospital-associated pathologies, such …

Staphylococcus aureus vaccine preclinical and clinical development: current state of the art

D Redi, C SPERTILLI RAFFAELLI… - NEW …, 2018 - usiena-air.unisi.it
Staphylococcus aureus is a major pathogen in both community and hospital settings. It is a
significant etiological agent to treat in healthcare-related infections due to both its ability to …

[HTML][HTML] The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus

HR Jahantigh, S Faezi, M Habibi, M Mahdavi… - Vaccines, 2022 - mdpi.com
Staphylococcus aureus (S. aureus) is an opportunistic pathogen that causes various
inflammatory local infections, from those of the skin to postinfectious glomerulonephritis …

[HTML][HTML] Staphylococcus aureus Putative Vaccines Based on the Virulence Factors: A Mini-Review

B Mirzaei, R Babaei, H Zeighami, M Dadar… - Frontiers in …, 2021 - frontiersin.org
Since the 1960s, the frequency of methicillin-resistant Staphylococcus aureus as a recurrent
cause of nosocomial infections has increased. Since multidrug-resistant Staphylococcus has …

Recent advances in Staphylococcus aureus infection: focus on vaccine development

S Ansari, RK Jha, SK Mishra, BR Tiwari… - Infection and drug …, 2019 - Taylor & Francis
Staphylococcus aureus normally colonizes the nasal cavity and pharynx. After breaching the
normal habitat, the organism is able to cause a number of infections at any site of the body …

Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines

J Broughan, R Anderson, AS Anderson - Expert review of vaccines, 2011 - Taylor & Francis
Staphylococcus aureus is a common human commensal organism and also a major cause
of nosocomial infections worldwide associated with high death rates, prolonged …

[HTML][HTML] Staphylococcus aureus vaccine strategy: promise and challenges

U Chand, P Priyambada, PK Kushawaha - Microbiological Research, 2023 - Elsevier
Staphylococcus aureus (S. aureus) is a leading and crucial infectious threat to global public
health due to the widespread emergence of antibiotic-resistant strains such as Methicillin …

[HTML][HTML] Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine

IL Scully, PA Liberator, KU Jansen… - Frontiers in …, 2014 - frontiersin.org
A key aspect of the pathogenesis of the Gram positive bacterium Staphylococcus aureus is
its ability to rapidly adapt to the host environment during the course of an infection. To …